"NIH—funded research helped scientists better understand cystic fibrosis, which led to Vertex Pharmaceuticals developing a cutting-edge treatment that Vought’s daughter Porter benefited from. In a 2021 Instagram post, Vought’s then-wife shared that the couple’s daughter had started Trikafta, a drug that has shown great promise in managing pulmonary issues associated with cystic fibrosis, which affects some 40,000 Americans."
https://www.motherjones.com/politics/2025/02/project-2025-vought-medical-funding/